<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedBookArticle><BookDocument><PMID Version="1">30725866</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK537181</ArticleId></ArticleIdList><Book><Publisher><PublisherName>StatPearls Publishing</PublisherName><PublisherLocation>Treasure Island (FL)</PublisherLocation></Publisher><BookTitle book="statpearls">StatPearls</BookTitle><PubDate><Year>2022</Year><Month>01</Month></PubDate><BeginningDate><Year>2022</Year><Month>01</Month></BeginningDate><Medium>Internet</Medium></Book><ArticleTitle book="statpearls" part="article-27738">Primary Sclerosing Cholangitis</ArticleTitle><Language>eng</Language><AuthorList Type="authors" CompleteYN="Y"><Author ValidYN="Y"><LastName>Rawla</LastName><ForeName>Prashanth</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Sovah Health, Martinsville, VA</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samant</LastName><ForeName>Hrishikesh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Ochsner Multiorgan Transplant Center</Affiliation></AffiliationInfo></Author></AuthorList><PublicationType UI="D000072643">Study Guide</PublicationType><Abstract><AbstractText>Primary sclerosing cholangitis (PSC) is a chronic and progressive cholestatic liver disorder of unknown etiology. Inflammation, fibrosis, and stricturing of intrahepatic and/or extrahepatic biliary ducts characterize PSC. PSC is usually a progressive disorder that leads to complications of cholestasis and liver failure. Median survival from the time of diagnosis to death without liver transplantation is around 10 years. Established subtypes of PSC are: 1. <i>Classic:</i> Affects small and large bile ducts. 2. <i>Small-duct:</i> Affects only small bile ducts. 3. <i>Associated with autoimmune hepatitis:</i> Affects small and large bile ducts. PSC is linked to ulcerative colitis and may be complicated by the onset of cholangiocarcinoma. Over the past few decades, the use of endoscopic retrograde cholangiopancreatography (ERCP) has led to more recognition of this disorder. There is no cure for PSC, and the condition is managed with immunosuppressive medications. Some patients end up with a liver transplant, but then they have to deal with an immunosuppressed state and its associated complications.</AbstractText><CopyrightInformation>Copyright © 2022, StatPearls Publishing LLC.</CopyrightInformation></Abstract><Sections><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s1">Continuing Education Activity</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s2">Introduction</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s3">Etiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s4">Epidemiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s5">Pathophysiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s6">Histopathology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s7">History and Physical</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s8">Evaluation</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s9">Treatment / Management</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s10">Differential Diagnosis</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s11">Prognosis</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s12">Complications</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s13">Postoperative and Rehabilitation Care</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s14">Consultations</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s15">Deterrence and Patient Education</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s16">Enhancing Healthcare Team Outcomes</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s17">Review Questions</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-27738" sec="article-27738.s18">References</SectionTitle></Section></Sections><ContributionDate><Year>2022</Year><Month>5</Month><Day>8</Day></ContributionDate><ReferenceList><Reference><Citation>Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology. 1999 Jul;30(1):325-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">10385674</ArticleId></ArticleIdList></Reference><Reference><Citation>Tischendorf JJ, Hecker H, Krüger M, Manns MP, Meier PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am J Gastroenterol. 2007 Jan;102(1):107-14.</Citation><ArticleIdList><ArticleId IdType="pubmed">17037993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazaridis KN, LaRusso NF. The Cholangiopathies. Mayo Clin Proc. 2015 Jun;90(6):791-800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4533104</ArticleId><ArticleId IdType="pubmed">25957621</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawla P, Sunkara T, Raj JP. Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives. J Inflamm Res. 2018;11:215-226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5961645</ArticleId><ArticleId IdType="pubmed">29844695</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ, American Association for the Study of Liver Diseases  Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010 Feb;51(2):660-78.</Citation><ArticleIdList><ArticleId IdType="pubmed">20101749</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012 May;56(5):1181-1188.</Citation><ArticleIdList><ArticleId IdType="pubmed">22245904</ArticleId></ArticleIdList></Reference><Reference><Citation>Molodecky NA, Kareemi H, Parab R, Barkema HW, Quan H, Myers RP, Kaplan GG. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology. 2011 May;53(5):1590-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21351115</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazaridis KN, LaRusso NF. Primary Sclerosing Cholangitis. N Engl J Med. 2016 Sep 22;375(12):1161-70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5553912</ArticleId><ArticleId IdType="pubmed">27653566</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismüller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma RK, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, Hampe J, Teufel A, Runz H, Rosenstiel P, Stiehl A, Vermeire S, Beuers U, Manns MP, Schrumpf E, Boberg KM, Schreiber S. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology. 2010 Mar;138(3):1102-11.</Citation><ArticleIdList><ArticleId IdType="pubmed">19944697</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet. 2018 Jun 23;391(10139):2547-2559.</Citation><ArticleIdList><ArticleId IdType="pubmed">29452711</ArticleId></ArticleIdList></Reference><Reference><Citation>Fickert P, Pollheimer MJ, Beuers U, Lackner C, Hirschfield G, Housset C, Keitel V, Schramm C, Marschall HU, Karlsen TH, Melum E, Kaser A, Eksteen B, Strazzabosco M, Manns M, Trauner M, International PSC Study Group (IPSCSG)  Characterization of animal models for primary sclerosing cholangitis (PSC). J Hepatol. 2014 Jun;60(6):1290-303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4517670</ArticleId><ArticleId IdType="pubmed">24560657</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindor KD, Kowdley KV, Harrison ME, American College of Gastroenterology  ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol. 2015 May;110(5):646-59; quiz 660.</Citation><ArticleIdList><ArticleId IdType="pubmed">25869391</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson KD, Chapman RW. Primary sclerosing cholangitis: a clinical update. Br Med Bull. 2015 Jun;114(1):53-64.</Citation><ArticleIdList><ArticleId IdType="pubmed">25981516</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, LaRusso NF, Lindor KD, Dickson ER. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc. 2000 Jul;75(7):688-94.</Citation><ArticleIdList><ArticleId IdType="pubmed">10907383</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawla P, Sunkara T, Muralidharan P, Raj JP. Update in global trends and aetiology of hepatocellular carcinoma. Contemp Oncol (Pozn) 2018;22(3):141-150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238087</ArticleId><ArticleId IdType="pubmed">30455585</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S, IBD Section of the British Society of Gastroenterology  Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011 May;60(5):571-607.</Citation><ArticleIdList><ArticleId IdType="pubmed">21464096</ArticleId></ArticleIdList></Reference></ReferenceList></BookDocument><PubmedBookData><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30725866</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle></PubmedArticleSet>
